Advertisement
Screener

CORCEPT THERAPEUTICS INC (CORT) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

CORCEPT THERAPEUTICS INC Increase (Decrease) in Accounts Payable

CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Accounts Payable of -$25.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-29

  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$18.24M.
  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$7.64M, a 160.81% decline year-over-year.
  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $6.00M.
  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $10.92M.
  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for fiscal 2025 was $25.07M.
  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for fiscal 2024 was -$2.02M, a 137.27% decline from fiscal 2023.
  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for fiscal 2023 was $5.42M, a 13.94% increase from fiscal 2022.
  • CORCEPT THERAPEUTICS INC increase (decrease) in accounts payable for fiscal 2022 was $4.76M.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 3 month as first filedIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 6 month as first filedIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 9 month as first filedIncrease (Decrease) in Accounts Payable 12 monthIncrease (Decrease) in Accounts Payable 12 month as first filedIncrease (Decrease) in Accounts Payable 158 monthIncrease (Decrease) in Accounts Payable 161 monthIncrease (Decrease) in Accounts Payable 164 monthIncrease (Decrease) in Accounts Payable 167 month
2026-06-30-$18.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
-$25.89M
10-Q · filed 2026-07-29
-$19.89M
derived: sum of 3 quarters · filed 2026-07-29
-$8.97M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31-$7.64M
10-Q · filed 2026-04-30
-$1.65M
derived: sum of 2 quarters · filed 2026-04-30
$9.28M
derived: sum of 3 quarters · filed 2026-04-30
$4.85M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$16.92M
derived: sum of 2 quarters · filed 2026-02-24
$12.50M
derived: sum of 3 quarters · filed 2026-07-29
$25.07M
10-K · filed 2026-02-24
2025-09-30$10.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$6.50M
derived: sum of 2 quarters · filed 2026-07-29
$19.07M
10-Q · filed 2025-11-04
$15.96M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30-$4.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$8.15M
10-Q · filed 2026-07-29
$5.04M
derived: sum of 3 quarters · filed 2026-07-29
$4.39M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$12.57M
10-Q · filed 2026-04-30
$12.93M
10-Q · filed 2025-05-05
$9.46M
derived: sum of 2 quarters · filed 2026-04-30
$8.82M
derived: sum of 3 quarters · filed 2026-04-30
$15.41M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$3.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$3.75M
derived: sum of 2 quarters · filed 2026-02-24
$2.84M
derived: sum of 3 quarters · filed 2026-02-24
-$2.02M
10-K · filed 2026-02-24
-$2.25M
10-K · filed 2025-02-26
2024-09-30-$649.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$5.95M
derived: sum of 2 quarters · filed 2025-11-04
$1.09M
10-Q · filed 2025-11-04
$1.62M
10-Q · filed 2024-10-30
$1.72M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$6.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$1.74M
10-Q · filed 2025-07-31
$1.73M
10-Q · filed 2024-07-29
$2.37M
derived: sum of 3 quarters · filed 2026-02-24
$10.96M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$4.86M
10-Q · filed 2025-05-05
-$4.22M
derived: sum of 2 quarters · filed 2026-02-24
$4.36M
derived: sum of 3 quarters · filed 2026-02-24
$1.21M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$637.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$9.22M
derived: sum of 2 quarters · filed 2026-02-24
$6.07M
derived: sum of 3 quarters · filed 2026-02-24
$5.42M
10-K · filed 2026-02-24
$5.78M
10-K · filed 2024-02-15
2023-09-30$8.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$5.43M
derived: sum of 2 quarters · filed 2024-10-30
$4.78M
10-Q · filed 2024-10-30
$9.03M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30-$3.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29
-$3.80M
10-Q · filed 2024-07-29
$440.00K
derived: sum of 3 quarters · filed 2025-02-26
$275.00K
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31-$649.00K
10-Q · filed 2024-05-01
$3.59M
derived: sum of 2 quarters · filed 2025-02-26
$3.43M
derived: sum of 3 quarters · filed 2025-02-26
$1.85M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$4.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$4.08M
derived: sum of 2 quarters · filed 2025-02-26
$2.50M
derived: sum of 3 quarters · filed 2025-02-26
$4.76M
10-K · filed 2025-02-26
2022-09-30-$165.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$1.74M
derived: sum of 2 quarters · filed 2023-11-01
$515.00K
10-Q · filed 2023-11-01
$879.00K
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30-$1.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$680.00K
10-Q · filed 2023-08-02
$1.04M
derived: sum of 3 quarters · filed 2024-02-15
-$1.61M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31$2.26M
10-Q · filed 2023-05-03
$2.62M
derived: sum of 2 quarters · filed 2024-02-15
-$37.00K
derived: sum of 3 quarters · filed 2024-02-15
$2.15M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$364.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
-$2.29M
derived: sum of 2 quarters · filed 2024-02-15
-$104.00K
derived: sum of 3 quarters · filed 2024-02-15
-$3.60M
10-K · filed 2024-02-15
2021-09-30-$2.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$468.00K
derived: sum of 2 quarters · filed 2022-11-03
-$3.96M
10-Q · filed 2022-11-03
$188.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$2.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$1.30M
10-Q · filed 2022-08-04
$2.85M
derived: sum of 3 quarters · filed 2023-02-28
$3.11M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$3.49M
10-Q · filed 2022-05-05
$656.00K
derived: sum of 2 quarters · filed 2023-02-28
$919.00K
derived: sum of 3 quarters · filed 2023-02-28
$2.27M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$4.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$4.41M
derived: sum of 2 quarters · filed 2023-02-28
$5.76M
derived: sum of 3 quarters · filed 2023-02-28
$3.16M
10-K · filed 2023-02-28
2020-09-30$263.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$1.61M
derived: sum of 2 quarters · filed 2021-11-03
-$988.00K
10-Q · filed 2021-11-03
$701.00K
derived: sum of 4 quarters · filed 2022-02-15
2020-06-30$1.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
-$1.25M
10-Q · filed 2021-07-29
$438.00K
derived: sum of 3 quarters · filed 2022-02-15
-$687.00K
derived: sum of 4 quarters · filed 2022-02-15
2020-03-31-$2.60M
10-Q · filed 2021-05-06
-$911.00K
derived: sum of 2 quarters · filed 2022-02-15
-$2.04M
derived: sum of 3 quarters · filed 2022-02-15
-$4.29M
derived: sum of 4 quarters · filed 2022-02-15
2019-12-31$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15
$564.00K
derived: sum of 2 quarters · filed 2022-02-15
-$1.69M
derived: sum of 3 quarters · filed 2022-02-15
-$735.00K
10-K · filed 2022-02-15
2019-09-30-$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03
-$3.38M
derived: sum of 2 quarters · filed 2020-11-03
-$2.42M
10-Q · filed 2020-11-03
-$8.16M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30-$2.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
-$1.30M
10-Q · filed 2020-08-04
-$7.03M
derived: sum of 3 quarters · filed 2021-02-23
$526.00K
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$953.00K
10-Q · filed 2020-05-04
-$4.78M
derived: sum of 2 quarters · filed 2021-02-23
$2.78M
derived: sum of 3 quarters · filed 2021-02-23
$1.32M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31-$5.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
$1.82M
derived: sum of 2 quarters · filed 2021-02-23
$370.00K
derived: sum of 3 quarters · filed 2021-02-23
-$389.00K
10-K · filed 2021-02-23
2018-09-30$7.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$6.10M
derived: sum of 2 quarters · filed 2019-11-07
$5.34M
10-Q · filed 2019-11-07
$7.71M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30-$1.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$2.21M
10-Q · filed 2019-08-01
$153.00K
derived: sum of 3 quarters · filed 2020-02-24
$4.29M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31-$759.00K
10-Q · filed 2019-05-09
$1.61M
derived: sum of 2 quarters · filed 2020-02-24
$5.75M
derived: sum of 3 quarters · filed 2020-02-24
$3.57M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31$2.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$6.50M
derived: sum of 2 quarters · filed 2020-02-24
$4.33M
derived: sum of 3 quarters · filed 2020-02-24
$6.29M
10-K · filed 2020-02-24
2017-09-30$4.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$1.96M
derived: sum of 2 quarters · filed 2018-11-02
$3.92M
10-Q · filed 2018-11-02
$1.90M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$2.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$216.00K
10-Q · filed 2018-08-09
-$2.23M
derived: sum of 3 quarters · filed 2019-02-26
-$7.00K
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$1.96M
10-Q · filed 2018-05-09
-$56.00K
derived: sum of 2 quarters · filed 2019-02-26
$2.17M
derived: sum of 3 quarters · filed 2019-02-26
$2.17M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31-$2.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$209.00K
derived: sum of 2 quarters · filed 2019-02-26
$208.00K
derived: sum of 3 quarters · filed 2019-02-26
$965.00K
10-K · filed 2019-02-26
2016-09-30$2.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$2.23M
derived: sum of 2 quarters · filed 2017-11-03
$2.98M
10-Q · filed 2017-11-03
$2.57M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$756.00K
10-Q · filed 2017-08-02
$341.00K
derived: sum of 3 quarters · filed 2018-02-28
-$279.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$757.00K
10-Q · filed 2017-05-02
$342.00K
derived: sum of 2 quarters · filed 2018-02-28
-$278.00K
derived: sum of 3 quarters · filed 2018-02-28
$1.05M
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31-$415.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
-$1.03M
derived: sum of 2 quarters · filed 2018-02-28
$289.00K
derived: sum of 3 quarters · filed 2018-02-28
-$561.00K
10-K · filed 2018-02-28
2015-09-30-$620.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$704.00K
derived: sum of 2 quarters · filed 2016-11-02
-$146.00K
10-Q · filed 2016-11-02
-$220.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30$1.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
$474.00K
10-Q · filed 2016-08-03
$400.00K
derived: sum of 3 quarters · filed 2017-03-06
-$235.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31-$850.00K
10-Q · filed 2016-05-04
-$924.00K
derived: sum of 2 quarters · filed 2017-03-06
-$1.56M
derived: sum of 3 quarters · filed 2017-03-06
-$2.63M
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31-$74.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
-$709.00K
derived: sum of 2 quarters · filed 2017-03-06
-$1.78M
derived: sum of 3 quarters · filed 2017-03-06
-$495.00K
10-K · filed 2017-03-06
2014-09-30-$635.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
-$1.71M
derived: sum of 2 quarters · filed 2015-11-06
-$421.00K
10-Q · filed 2015-11-06
-$377.00K
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30-$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$214.00K
10-Q · filed 2015-08-07
$258.00K
derived: sum of 3 quarters · filed 2016-03-10
-$438.00K
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$1.28M
10-Q · filed 2015-05-08
$1.33M
derived: sum of 2 quarters · filed 2016-03-10
$633.00K
derived: sum of 3 quarters · filed 2016-03-10
$1.40M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$44.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
-$652.00K
derived: sum of 2 quarters · filed 2016-03-10
$118.00K
derived: sum of 3 quarters · filed 2016-03-10
-$1.42M
10-K · filed 2016-03-10
2013-09-30-$696.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$74.00K
derived: sum of 2 quarters · filed 2014-11-07
-$1.47M
10-Q · filed 2014-11-07
$763.00K
derived: sum of 4 quarters · filed 2015-03-13
2013-06-30$770.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
-$771.00K
10-Q · filed 2014-08-08
$1.46M
derived: sum of 3 quarters · filed 2015-03-13
-$1.20M
derived: sum of 4 quarters · filed 2015-03-13
2013-03-31-$1.54M
10-Q · filed 2014-05-12
$689.00K
derived: sum of 2 quarters · filed 2015-03-13
-$1.97M
derived: sum of 3 quarters · filed 2015-03-13
$179.00K
derived: sum of 4 quarters · filed 2015-03-13
2012-12-31$2.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
-$431.00K
derived: sum of 2 quarters · filed 2015-03-13
$1.72M
derived: sum of 3 quarters · filed 2015-03-13
$193.00K
10-K · filed 2015-03-13
2012-09-30-$2.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$510.00K
derived: sum of 2 quarters · filed 2013-11-12
-$2.04M
10-Q · filed 2013-11-12
$508.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$2.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$624.00K
10-Q · filed 2013-08-09
$3.17M
derived: sum of 3 quarters · filed 2014-03-14
$1.94M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31-$1.53M
10-Q · filed 2013-05-08
$1.02M
derived: sum of 2 quarters · filed 2014-03-14
-$207.00K
derived: sum of 3 quarters · filed 2014-03-14
$219.00K
derived: sum of 4 quarters · filed 2014-03-14
$2.08M
10-Q · filed 2012-05-10
2011-12-31$2.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
$1.32M
derived: sum of 2 quarters · filed 2014-03-14
$1.75M
derived: sum of 3 quarters · filed 2014-03-14
$2.79M
10-K · filed 2014-03-14
$3.61M
10-K · filed 2012-03-13
2011-09-30-$1.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
-$799.00K
derived: sum of 2 quarters · filed 2012-11-08
$249.00K
10-Q · filed 2012-11-08
-$611.00K
derived: sum of 4 quarters · filed 2013-03-15
$1.07M
10-Q · filed 2011-11-08
2011-06-30$426.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$1.47M
10-Q · filed 2012-08-09
$614.00K
derived: sum of 3 quarters · filed 2013-03-15
$1.12M
derived: sum of 4 quarters · filed 2013-03-15
$2.29M
10-Q · filed 2011-08-09
2011-03-31$1.05M
10-Q · filed 2012-05-10
$188.00K
derived: sum of 2 quarters · filed 2013-03-15
$692.00K
derived: sum of 3 quarters · filed 2013-03-15
2010-12-31-$860.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
-$356.00K
derived: sum of 2 quarters · filed 2013-03-15
-$453.00K
10-K · filed 2013-03-15
2010-09-30$504.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$407.00K
10-Q · filed 2011-11-08
2010-06-30-$97.00K
10-Q · filed 2011-08-09
2009-12-31-$34.00K
10-K · filed 2012-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52